Are there ketamine clinics located directly in Los Alamos?
Currently, our directory does not list any specialty clinics providing ketamine or Spravato treatments physically within Los Alamos. Residents exploring these therapies typically commute to nearby cities like Santa Fe, Rio Rancho, or Albuquerque. Consult your primary physician for guidance on seeking specialized referrals in the region.
Why is an escort required for Spravato treatment?
Both esketamine and off-label ketamine can cause significant sedation, dissociation, and delayed reaction times. For your safety and the safety of the public, clinical protocols strictly forbid driving until the next day, after a restful sleep. A known, responsible adult must accompany you to drive you home safely.
How does winter weather in Los Alamos affect treatment schedules?
Los Alamos is situated at a high elevation where mountain snow and icy conditions are common. Because therapies require multiple in-person sessions over a set period, unpredictable winter weather can disrupt travel. Patients should discuss contingency plans and flexible scheduling with their clinic during the winter months.
Does health insurance cover IV ketamine infusions?
Intravenous (IV) ketamine is utilized off-label for psychiatric care and is not FDA-approved for this specific purpose. Consequently, most insurance providers do not cover the cost of the infusions, requiring patients to pay out-of-pocket. However, standard psychiatric evaluations alongside the treatment might be eligible for partial coverage.
Can Spravato be prescribed for chronic pain?
No, Spravato is solely FDA-approved for specific adult depression indications, such as treatment-resistant depression or major depressive disorder with acute suicidal ideation. It is not approved or indicated for the treatment of chronic pain, OCD, PTSD, or anxiety disorders. Clinical criteria must be met before prescription.
Are home administration options available for these treatments?
Spravato is heavily restricted and is never permitted for home administration; it requires in-clinic supervision. Some practitioners prescribe compounded sublingual ketamine for off-label home use. However, these formulations are not FDA-approved for psychiatric care, and regulatory agencies strongly warn against their use without direct, on-site medical monitoring.